---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-005176"
form_type: "8-K"
ticker: "EXOZ"
cik: "0002010788"
company_name: "EXOZYMES INC."
filed_at: "2026-02-05T23:59:59+00:00"
generated_at: "2026-05-16T04:34:04.106993+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# eXoZymes reports 535g NCT pilot run at 99% conversion, 90% yield, 99.6% purity

## Summary
- Achieved ~99% reaction conversion, 90% isolated yield, and 535 g of NCT at 99.6% pharma-grade purity from a 100L pilot run.
- Production executed externally by Cayman Chemical, demonstrating protocol transferability and operational robustness.
- High-purity NCT is now available for formulation development and partner sample requests.
- Company expects 2026 focus on commercial NCT supply chain, expanded volumes, and strategic partnerships.

## SEC filing metadata
- accession: 0001493152-26-005176
- form_type: 8-K
- ticker: EXOZ
- cik: 0002010788
- company_name: EXOZYMES INC.
- filed_at: 2026-02-05T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2010788/000149315226005176/0001493152-26-005176-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2010788/000149315226005176/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-005176
- JSON: https://secwatch.observer/filing/0001493152-26-005176.json
- Plain text: https://secwatch.observer/filing/0001493152-26-005176.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.